Cipher Pharmaceuticals (CPH) Price & Analysis

Compare

85 Followers

CPH Stock Chart & Stats

Day’s Range― - ―

52-Week RangeC$8.01 - C$19.69

Previous CloseN/A

Volume17.82K

Average Volume (3M)18.28K

Market Cap

C$321.31M

Enterprise ValueC$276.07M

Total Cash (Recent Filing)C$17.84M

Total Debt (Recent Filing)$40.58M

Price to Earnings (P/E)25.0

Beta-0.28

Next Earnings

Aug 07, 2025

EPS Estimate

0.21

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.14

Shares Outstanding25,622,940

10 Day Avg. Volume13,202

30 Day Avg. Volume18,283

Financial Highlights & Ratios

PEG Ratio-0.83

Price to Book (P/B)4.75

Price to Sales (P/S)0.00

P/FCF Ratio29.01

Enterprise Value/Market Cap0.86

Enterprise Value/Revenue2.65

Enterprise Value/Gross Profit11.45

Enterprise Value/Ebitda5.63

Forecast

1Y Price Target

C$14.93

Price Target Upside19.04% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

Cipher Pharmaceuticals News

PremiumCompany Announcements

Cipher Pharmaceuticals’ Shareholders Approve Key Resolutions at Annual Meeting

21d ago

PremiumThe Fly

Cipher Pharmaceuticals price target raised to C$13 from C$12.50 at Canaccord

2M ago

PremiumCompany Announcements

Cipher Pharmaceuticals Reports Strong Revenue Growth in Q1 2025

2M ago

PremiumCompany Announcements

Cipher Pharmaceuticals’ Earnings Call Highlights Growth and Challenges

2M ago

PremiumCompany Announcements

Cipher Pharmaceuticals Reports Strong Q1 2025 Results and Strategic Debt Repayment

2M ago

PremiumPre-Earnings

CPHRF Upcoming Earnings Report: What to Expect?

2M ago

PremiumCompany Announcements

Cipher Pharmaceuticals to Announce Q1 2025 Financial Results

2M ago

PremiumCompany Announcements

Cipher Pharmaceuticals’ Natroba™ Gains Preferred Status in Illinois Medicaid

2M ago

See All TSE:CPH News

See All News >

Financials

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

1.44% Insiders

0.91%

Mutual Funds

0.72% Other Institutional Investors

96.83% Public Companies and

Individual Investors

Detailed Ownership Overview >

CPH FAQ

What was Cipher Pharmaceuticals Inc’s price range in the past 12 months?

Cipher Pharmaceuticals Inc lowest stock price was C$8.01 and its highest was C$19.69 in the past 12 months.

What is Cipher Pharmaceuticals Inc’s market cap?

Cipher Pharmaceuticals Inc’s market cap is C$321.31M.

When is Cipher Pharmaceuticals Inc’s upcoming earnings report date?

Cipher Pharmaceuticals Inc’s upcoming earnings report date is Aug 07, 2025 which is in 34 days.

How were Cipher Pharmaceuticals Inc’s earnings last quarter?

Cipher Pharmaceuticals Inc released its earnings results on May 08, 2025. The company reported C$0.136 earnings per share for the quarter, missing the consensus estimate of C$0.144 by -C$0.008.

Is Cipher Pharmaceuticals Inc overvalued?

According to Wall Street analysts Cipher Pharmaceuticals Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Cipher Pharmaceuticals Inc pay dividends?

Cipher Pharmaceuticals Inc does not currently pay dividends.

What is Cipher Pharmaceuticals Inc’s EPS estimate?

Cipher Pharmaceuticals Inc’s EPS estimate is 0.21.

How many shares outstanding does Cipher Pharmaceuticals Inc have?

Cipher Pharmaceuticals Inc has 25,622,940 shares outstanding.

What happened to Cipher Pharmaceuticals Inc’s price movement after its last earnings report?

Cipher Pharmaceuticals Inc reported an EPS of C$0.136 in its last earnings report, missing expectations of C$0.144. Following the earnings report the stock price went down -3.537%.

Which hedge fund is a major shareholder of Cipher Pharmaceuticals Inc?

Currently, no hedge funds are holding shares in TSE:CPH

Cipher Pharmaceuticals Stock Smart Score

Neutral

Fundamentals

Return on Equity

9.69%

Trailing 12-Months

Asset Growth

76.20%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Cipher Pharmaceuticals Inc

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the acquisition, licensing, and commercialization of dermatology products. The company operates primarily in North America and specializes in bringing innovative and differentiated products to market through its established sales and marketing infrastructure.

CPH Earnings Call

Q1 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

The earnings call presented a strong growth narrative driven by the Natroba acquisition and Canadian product portfolio, leading to significant revenue and EBITDA growth. However, this was somewhat offset by declines in licensing revenue, particularly from Absorica, and increased expenses. The company's strategic debt repayment and pursuit of growth opportunities provide a balanced outlook.Read More>

CPH Stock 12 Month Forecast

Average Price Target

C$14.93

▲(19.04%Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3":"C$3","7":"C$7","11":"C$11","15":"C$15","19":"C$19"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":16.910591229,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">C$16.91</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14.9275018158,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">C$14.93</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":12.9308295984,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">C$12.93</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3,7,11,15,19],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2024","6":"Sep<br/>2024","9":"Dec<br/>2024","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.08,14.297737786846154,14.515475573692308,14.733213360538462,14.950951147384616,15.16868893423077,15.386426721076923,15.604164507923077,15.821902294769231,16.039640081615385,16.25737786846154,16.475115655307693,16.692853442153847,{"y":16.910591229,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.08,14.145192447369231,14.210384894738462,14.275577342107692,14.340769789476923,14.405962236846154,14.471154684215385,14.536347131584614,14.601539578953846,14.666732026323077,14.731924473692308,14.797116921061537,14.862309368430768,{"y":14.9275018158,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.08,13.9916022768,13.9032045536,13.8148068304,13.7264091072,13.638011384,13.5496136608,13.4612159376,13.3728182144,13.2844204912,13.196022768,13.1076250448,13.0192273216,{"y":12.9308295984,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":4.3,"date":1696118400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.9,"date":1706745600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.22,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.58,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.15,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.34,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.99,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.69,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.235,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.29,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.12,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.58,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.08,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >